Neisseria gonorrhoeae multi antigen sequence typing STs of 320 Neisseria gonorrhoeae isolates and their association with antimicrobial susceptibility phenotypes
| ST | n (%)* | Antimicrobial susceptibility phenotype | ||||
|---|---|---|---|---|---|---|
| Susceptible n (%) | CMTR n (%) | TRNG n (%) | CMRNG n (%) | Other n (%) | ||
| 25 | 46 (14.4) | 40† (87.0) | 6 (13.0) | – | – | – |
| 3655‡ | 23 (7.2) | 1 (4.4) | 22† (95.6) | – | – | – |
| 3654‡ | 21 (6.5) | – | 12 (57.1) | – | 9† (42.9) | – |
| 3657‡ | 15 (4.7) | 5 (33.3) | 10 (66.7) | – | – | – |
| 3672‡ | 14 (4.4) | 2 (14.2) | 12† (85.8) | – | – | – |
| 3556 | 13 (4.0) | 6 (46.1) | 7 (53.9) | – | – | – |
| 921 | 13 (4.0) | 1 (7.6) | 12† (92.3) | – | – | – |
| 3656‡ | 13 (4.0) | 4 (30.7) | 8 (61.5) | – | 1 (7.6) | – |
| 3711 | 10 (3.1) | – | – | 10† (100.0) | – | – |
| 508 | 10 (3.1) | 1 (10.0) | 8 (80.0) | – | 1 (10.0) | – |
| 3653‡ | 8 (2.5) | 1 (12.5) | 7 (87.5) | – | – | – |
| 3714‡ | 7 (2.2) | 1 (14.3) | 6 (85.7) | – | – | – |
| 3671‡ | 7 (2.2) | 4 (57.2) | 3 (42.8) | – | – | – |
| 4585‡ | 6 (1.9) | 5 (83.3) | 1 (16.7) | – | – | – |
| 210 | 5 (1.6) | 2 (40.0) | 3 (60.0) | – | – | – |
| Other STs (1–4 isolates/ST) | 109 (34.1) | 31 (28.4) | 64 (58.7) | 3 (2.8) | 2 (1.8) | 9 (8.3) |
| Total | 320 | 104 (32.5) | 181 (56.6) | 13 (4.0) | 13 (4.0) | 9 (2.8) |
*n, number of isolates.
†Significant (p<0.5) using Yates’ χ2 analysis.18
‡New STs.
ST, strain type; CMRNG, chromosomally resistant N gonorrhoeae; CMTR, chromosomally-mediated tetracycline resistance; TRNG, tetracycline resistant N gonorrhoeae; PPNG, penicillinase producing N gonorrhoeae (n=1); PPNG/CMTR (n=1); ciprofloxacin resistant, CipR (n=2); azithromycin resistant, AziR (n=1); TRNG/CipR (n=1); CMTR/CipR (n=2); CMTR/AziR (n=1).